Co-encapsulation of PI3-Kδ/HDAC6 dual inhibitor and Navitoclax in Quatramer™ nanoparticles for synergistic effect in ER+ breast cancer
- Resource Type
- Article
- Source
- In
International Journal of Pharmaceutics 25 November 2022 628 - Subject
- Language
- ISSN
- 0378-5173